MARK HERMAN to Fructose
This is a "connection" page, showing publications MARK HERMAN has written about Fructose.
Connection Strength
4.919
-
A Systems Approach Dissociates Fructose-Induced Liver Triglyceride from Hypertriglyceridemia and Hyperinsulinemia in Male Mice. Nutrients. 2021 Oct 18; 13(10).
Score: 0.672
-
Molecular aspects of fructose metabolism and metabolic disease. Cell Metab. 2021 12 07; 33(12):2329-2354.
Score: 0.670
-
Metabolic liver disease - what's in a name? Nat Rev Endocrinol. 2021 02; 17(2):79-80.
Score: 0.639
-
Fructose metabolism and metabolic disease. J Clin Invest. 2018 02 01; 128(2):545-555.
Score: 0.519
-
Intestinal, but not hepatic, ChREBP is required for fructose tolerance. JCI Insight. 2017 12 21; 2(24).
Score: 0.515
-
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. Mol Metab. 2017 01; 6(1):14-21.
Score: 0.478
-
ChREBP regulates fructose-induced glucose production independently of insulin signaling. J Clin Invest. 2016 11 01; 126(11):4372-4386.
Score: 0.473
-
The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis. Trends Endocrinol Metab. 2016 10; 27(10):719-730.
Score: 0.465
-
Fructose: metabolic signal and modern hazard. Nat Metab. 2026 May; 8(5):1019-1033.
Score: 0.229
-
Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis. Cell Metab. 2018 Jun 05; 27(6):1249-1262.e4.
Score: 0.132
-
The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans. Mol Metab. 2017 11; 6(11):1493-1502.
Score: 0.126